References
- American Cancer Society. Cancer facts & figures 2014. Atlanta: American Cancer Society; 2014
- Kesharwani P, Tekade RK, Jain K, Jain NK. Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer. Biomaterials 2014;35:5539–48
- Kesharwani P, Ghanghoria R, Jain NK. Carbon nanotube exploration in cancer cell lines. Drug Discov Today 2012;17:1023–30
- Kesharwani P, Tekade RK, Gajbhiye V, et al. Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison. Nanomed Nanotech Biol Med 2011;7:295–304
- Kesharwani P, Jain K, Jain NK. Dendrimer as nanocarrier for drug delivery. Prog Polym Sci 2014;39:268–307
- Kesharwani P, Tekade RK, Jain K, Jain NK. Formulation development and in vitro–in vivo assessment of fourth generation PPI dendrimer as cancer targeting vector. Nanomed (Lond) 2014 [Epub ahead of print]
- Kesharwani P, Gajbhiye V, Tekade RK, Jain NK. Evaluation of dendrimer safety and efficacy through cell line studies. Curr Drug Targets 2011;12:1478–97
- Jain K, Kesharwani P, Gupta U, Jain NK. Dendrimer toxicity: let's meet the challenge. Int J Pharm 2010;394:122–42
- Gupta U, Dwivedi SK, Bid HK, et al. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells. Int J Pharm 2010;393:185–96
- Tekade RK, Dutta T, Tyagi A, et al. Surface-engineered dendrimers for dual drug delivery: a receptor up-regulation and enhanced cancer targeting strategy. J Drug Target 2008;16:758–72
- Agarwal A, Gupta U, Asthana A, Jain NK. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials 2009;30:1–9
- Lee RJ, Low PS. Delivery of liposomes into cultured KB cells via folate receptor mediated endocytosis. J Biol Chem 1994;269:3198–204
- Morrison TR, Boyd RN. Organic chemistry. 6th ed. Noida (Uttar Pradesh), India: Dorling Kindrsley Publishers, Prentice Hall of India Pvt. Ltd; 2005
- Finar IL. Organic chemistry. 5th ed. Singapore: Pearson Edu. Publishers; 2004
- Zhuo RX, Du B, Lu ZR. In-vitro release of 5-fluorouracil with cyclic core dendritic polymer. J Control Release 1999;57:249–57
- Kojima C, Kono K, Maruyama K, Takagishi T. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjug Chem 2000;11:910–17
- Malik N, Wiwattanapatapee R, Klopsch R, et al. Dendrimers: relationship between structure and biocompatibility in vitro and preliminary studies on the biodistribution of 125I-labeled polyamidoamine dendrimers in vivo. J Control Release 2000;65:133–48
- Gajbhiye V, Kumar PV, Tekade RK, Jain NK. PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist. J Med Chem 2009;44:1155–66
- Khopade AJ, Caruso F, Tripathi P, et al. Effect of dendrimer on entrapment and release of bioactive from liposomes. Int J Pharm 2002;232:157–62
- Asthana A, Chauhan AS, Diwan PV, Jain NK. Poly (amidoamine) (PAMAM) dendritic nanostructures for controlled site specific delivery of acidic anti-inflammatory active ingredient. AAPS PharmSciTech 2005;6:536–42
- Dutta T, Agashe HB, Kumar PV, et al. Dendrosome-based gene delivery. J Exp Nano Sci 2006;2:235–48
- Kumar PV, Agashe HB, Dutta T, Jain NK. PEGylated dendritic architecture for development of a prolonged drug delivery system for an antitubercular drug. Curr Drug Deliv 2007;4:11–19
- Wang DJ, Imae T. Fluorescence emission from dendrimer & its pH dependence. J Am Chem Soc 2004;126:13204–5
- Gupta U, Agashe H, Jain NK. Polypropylene imine dendrimer mediated solubility enhancement: effect of pH and functional groups of hydrophobes. J Pharm Sci 2007;10:358–67
- Kesarwani P, Jain K, Tekade RK, et al. Spectrophotometric estimation of Paclitaxel. Int J Adv Pharm Sci 2011;2:29–32
- Jain S, Kesharwani P, Tekade RK, Jain NK. One platform comparison of solubilization potential of dendrimer with some solubilizing agents. Drug Dev Ind Pharm 2014 [Epub ahead of print]. doi:10.3109/03639045.2014.900077
- Kulhari H, Pooja D, Singh MK, Chauhan AS. Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation. Drug Dev Ind Pharm 2013 [Epub ahead of print]. doi:10.3109/03639045.2013.858735